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 Cystic fibrosis is a genetic disorder caused by mutations of the cystic fibrosis 
transmembrane conductance regulator (CFTR) protein. CFTR serves to control the gradient of 
chloride and bicarbonate ions across the cellular membrane of epithelial tissues (e.g., mucosa, 
intestinal walls, and lungs). Excess chloride on the inside of epithelial cells causes mucus in the 
lungs to become very thick. This thickening is responsible for a patients’ characteristic thick 
sputum, coughing, and trouble breathing. The thick mucus also creates an ideal environment for 
opportunistic bacteria like Pseudomonas aeruginosa and Mycobacterium tuberculosis to take 
residence and proliferate. Very little is known about the transmembrane structure of CFTR, but 
with current therapies a single mutation can shorten a person’s life by about 50%.  
Many researchers have attempted to bypass the CFTR protein and synthesize anion 
shuttle transporters or transmembrane pores. The research presented here focuses on the 
synthesis of anion-responsive amino acids, for eventual incorporation into membrane-spanning 
peptides. Amino acids 2.1 and 2.2 were successfully synthesized from commercially available 
Fmoc-Glu-OtBu and Fmoc-Asp-OtBu through the conversion of an acid azide into an isocyanate 
via a Curtis Rearrangement. An N-substituted-4-amino-naphthalimide was chosen as the 
chromophore due to its ability to absorb and emit light at a significantly longer wavelength than 
those produced by naturally occurring amino acids. The fluorescence provides an indirect insight 
into the binding strength of the novel amino acids, and eventually designer peptides, to various 
biologically relevant anions. The fluorescence can also be used by a researcher to learn more 
about a peptides concentration, location, microenvironment, structure, and mechanism of action. 
The presence of a fluorenylmethyloxycarbonyl (Fmoc) protecting group allows a researcher to 
use standard solid phase peptide synthesis protocols to produce either a known peptide or any 
imaginable variation. Fluorescent amino acids are useful tools in grasping a better understanding 
of protein channelopathies such as cystic fibrosis. One day, the use of synthetic peptide ion 
channels will be an effective therapy to alleviate the many symptoms and even the causes of 
death that afflicts the many patients suffering from channelopathies today. 
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CHAPTER 1: SYNTHETIC ION TRANSPORTERS AND TREATING ION 
CHANNEL PATHOLOGIES 
1.1 Membrane Transport of Anions and Cystic Fibrosis 
 To function properly, cells must maintain proper concentration gradients of small anions 
such as chloride (Cl-) and bicarbonate (HCO3
-) across their membranes. However, these charged 
species cannot cross the nonpolar membrane core on their own. When protein-mediated ion 
transport across lipid bilayers has been altered to the point of causing disease, a “channelopathy” 
occurs. Cystic fibrosis is perhaps the best-known. It burdens pediatric patients with serious 
complications and a 50% chance of death before the age of 12 without immediate and constant 
medical care.(1,2) Cystic fibrosis is caused by a genetic mutation that leads to a fatal change to the 
chloride channel protein cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is 
a 1480 residue membrane protein that is part of the ATP-binding cassette superfamily of 
proteins. It is made up of two transmembrane portions (TMD), two nucleotide binding domains 
(NBD) that sit just on the inside of a cellular bilayer, and a regulatory domain.  
Many mutations have been implicated as the cause for this disease but the most common 
is the deletion of a phenylalanine at the 508th position in the N-terminus NBD. This deletion 
causes the protein to improperly fold, leading to dysfunction and eventual premature degradation 
by the cell.(3,4) The key role of F508 in cystic fibrosis was deduced by the Thomas group out of 
the University of Texas at Dallas. They performed multiple missense mutations at the F508 
position producing several mutant proteins with replacement residues instead of a 
phenylalanine.(5) At lower temperatures the replacement of phenylalanine with other amino acids 
provided a sequence that would fold into a tertiary structure similar to the wild type protein, and 
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function as such; with exception to tryptophan. The group also performed Western blot 
experiments to deduce the ability for the mutant NBD’s to associate with the other domains that 
make up the total CFTR protein. These results along with other data led them to conclude that 
delF508 results in not only poor folding of the NBD, but also disruption to the surface of the 
NBD superstructure and thus the inability for it to associate with the other components of CFTR, 
specifically the transmembrane channel. If the nucleotide binding domain is unable to associate 
with and activate the TMD then the channel will not open for chloride transport. 
What can be lost in the complex biology of the many causes of cystic fibrosis is the 
macro-physiology. A patient with cystic fibrosis has a dysfunctional chloride channel that when 
operable is responsible for the balance of ions in tissues that produce mucus, sweat, saliva, tears, 
and digestive enzymes.(6) The cysts that form on pancreatic tissue of patients with CF were so 
severe that it would inevitably lead to scarring or fibrosis and thus originated the name cystic 
fibrosis. Unfortunately, in the 19th century the scarring was only noticed during the autopsies 
performed on young children. In the 17th century children were ‘cursed and destined for death’ 
upon kissing the brow of a newborn and tasting salt. The connection that children with CF had 
saltier sweat led to the sweat test for diagnosis of CF in 1952 by Paul di Sant' Agnese. The most 
recognizable symptom of patients with cystic fibrosis is the difficulty they have with breathing 
and the thick sputum that they often cough up. Functional, wild-type CFTR allows for the flow 
of chloride back-and-forth across the cell membrane of lung epithelial tissue in response to the 
need for increased or decreased fluidity of the mucus. The trouble with breathing and the thick 
sputum are a direct result from the proteins’ inability to transport chloride out of the cell into the 
extracellular matrix. As the chloride concentration increases on the inside of the cell so does the 
osmotic pressure; drawing water into the cell and causing the extracellular mucus to become very 
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thick. While, alone, the trouble breathing can be a life complicating symptom, it is tolerable and 
not deadly; however, the thick mucus is full of peptides, carbohydrates, minerals, and salts which 
make it a perfect medium for bacterial growth. In modern times, patients with cystic fibrosis can 
live well into their 30’s with some making 40 or even 50, but this typically requires constant 
medical care and invasive procedures like lung transplantation.(2-6) While the symptoms are 
manageable, prophylactic antibiotic treatments breed ever stronger and more resistant 
opportunistic pathogens, eventually leading to an incurable infection and death. 
The development of small molecule therapies for 
channelopathies like cystic fibrosis is of ever increasing 
importance. Currently, only one pharmaceutical, Ivacaftor, 
is available on the market as a CFTR modulator, which 
targets the underlying cause of CF; a few other 
formulations are currently in phase III of clinical trials.(5,6) 
Ivacaftor acts to restore the CFTR proteins ability to transport chloride; however, until recently it 
was only available to patients with the G551D mutation, making up only a small percentage of 
the patient population.(6) Ivacaftor has recently been made available by the FDA to nine 
additional mutations, but these still fail to add up to anything greater than 3.0 % of the patient 
population. Several research groups have simply bypassed the CFTR protein and attempted to 
synthetically restore chloride transport using small molecular shuttles or pore forming cyclic 
peptides. 
 
 
Figure 1.1: Ivacaftor 
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1.2 Synthetic Anion Transporters 
1.2.1 Shuttles 
 Busschaert et. al. have developed a tripodal tris(2-ureidoethyl)amine moiety that is able 
to act as a chloride/bicarbonate antiporter shuttle.(1,7) Urea is a commonly used hydrogen-bond 
donor in the production of neutral anion receptors. The shuttle produced by Busschaert is able to 
slide through the non-polar portion of a bilayer by simply forming a cage around the anion, and 
effectively masking the charge. 
 
 
 
 
 
  
Another genre of anion shuttles made popular out of the University of Texas at Austin by 
the Sessler group are calix[4]pyrroles (Figure 1.3).(8,9) Again the molecule masks the charge of 
the anion and acts as a shuttle to transport the anion across a lipid bilayer. In this case the 
calix[4]pyrrole forms a cup and stabilizes the anion through hydrogen bonding. A paper 
published in 2006 by Sessler and coworkers used isothermal titration calorimetry and nuclear 
magnetic resonance to determine how differences in solvents and countercations could affect the 
ability for the calices to bind to an anion.(30) The group was able to extract Kassoc constants for 
Cl- 
Figure 1.2: A representation of how a tris(2-amino-ethyl)amine based urea or thiourea derivative forms a 
cage around a chloride atom and conceals its charge as the complex shuttles across a lipid bilayer. 
5 
 
meso-octamethylcalix[4]pyrrole, 6, binding with chloride through their ITC experiments. In 
acetonitrile the Kassoc was found to be 1.9 ± 0.4 x 10
5 and 2.2 ± 0.2 x 105 M-1 for 
tetraethylammonium chloride and 
tetrabutylammonium chloride, respectively. The 
researchers found that it was difficult to develop 
a pattern for whether tetrabutylammonium or 
tetraethylammonium was the better 
countercation for forming the calix + anion 
complex. They also found it difficult to see a 
pattern in how the polarity of the solvent 
affected complexation. Nonetheless, Gale et. al. were able to provide significant evidence that 
calix[4]pyrrole and its derivatives are very effective binders to chloride and are great transporters 
of the anion across lipid bilayers. The calix[4]pyrrole system has been expanded on to include 
additional bridged anion binding moieties, such as triazole rings,(10) and now include 
calix[4]thiophenes and calix[4]furans.(11) 
 
1.2.2 Transmembrane Structures 
Ideally, an anion transporting therapeutic would come in the form of an inhalant. Cystic 
fibrosis patients have an increased concentration of chloride on the inside of epithelial cells and 
thus a therapeutic would need to have the ability to encourage anion transport whilst originating 
on the exterior of a cellular matrix. While anion shuttles provide a mechanism for the transport 
of selective anions, they lack a sense of permanency. If they were to be used for the treatment of 
cystic fibrosis, patients would have to be constantly dosed with the drug because free-floating 
Figure 1.3: meso-octamethylcalix[4]pyrrole 
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shuttles lack an ability to control localization; and this opens questions as to how rapidly these 
molecules will diffuse through tissue and no longer remain in the most exterior epithelial cells of 
respiratory tissues. Another class of anion transporting structures are known as self-assembling 
transmembrane superstructures or channels. 
Dr. Steven L. Regen at Lehigh University 
synthesized one of the earliest attempts at anion 
transport using a mimic of the antimicrobial 
sterol squalamine (Figure 1.4).(12,13) The 
compound showed surprising sensitivity for 
anions as well as membrane selectivity. The 
experiment was carried out using liposomes 
made from phosphatidylglycerol and 
phosphatidylcholine lipids hydrated in buffer 
containing sodium chloride, pyranine and HEPES 
buffer (pH 7.0). Using the fluorescent, pH-
sensitive dye pyranine the Regen group was able 
to indirectly observe a change in pH after introduction of the squalamine-like derivative (Figure 
1.4(b)). By trapping the water soluble fluorophore on the inside of liposomes the group could 
measure the rate at which the pH changed through a rate of change in fluorescence. To ensure 
that the pH change was not due to sodium transport 23Na+-NMR experiments were performed on 
liposomes with 23NaCl. No transport of sodium was seen and thus the group was able to 
conclude that the change in pH across the lipid bilayers was a result of either H+/Cl- symporter or 
Cl-/OH- antiporter activity. 
Figure 1.4: (a) Squalamine and 
(b) anion transporter derivative 
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The Ghadiri group at The Scripps Research Institute 
have produced cyclic peptides with all of the side 
chains radiating out from the center by alternating the 
amino acid sequence with D and L stereoisomers. An 
example of a single ring is represented in Figure 1.5. 
The resulting peptides can self-assemble into 
nanotubes through a synthetic lipid bilayer by means 
of several β-sheetlike backbone hydrogen bonds that 
stabilize the structure without the formation of a net 
dipole that is commonly known to occur in α-helical peptide species.(14,15) The Ghadiri group 
found that with charge modification (net + or -) of the terminal cyclic rings led to some level of 
selectivity for cation transport. From a paper published in 2001 by Ghadiri et. al. it appears that 
the only method for anion selectivity is mediated through pore diameter; which is achieved by 
simply decreasing or increasing the number of amino acid residues that are used to make the 
original ring.(16,17) 
 What anion shuttles lack in permanency they make up for in selectivity and where 
nanotubes have the potential as a long term channel they lack selectivity for anions. The work of 
Jessen et. al. have expanded on the idea that urea moieties make effective hydrogen bond 
receptors for anions and incorporated them into a fluorescent pseudo-lipid molecule.(18) 
Figure 1.5: Generic example of a cyclic 
peptide that contains alternating D- and L- 
amino acids. 
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This structure was designed to spontaneously incorporate into a liposomal membrane in a 
fashion that would localize the ureido, neutral anion receptor inside the nonpolar region of the 
bilayer. The urea moiety has the potential to stabilize and conceal the negative charge of an 
anion during its transition through a lipid bilayer.(1) The fluorescence aspect can be used as 
evidence to signal whether the compound had localized into the lipid bilayer or remained in the 
aqueous solution due to solvatochromism. Finally, the fluorescence was also used as a technique 
to measure the novel molecules ability to bind to a series of anions. Jessen and coworkers found 
that the pseudo lipid had a strong affinity for several anions (Kassoc (M
-1)): bicarbonate (>105), 
dihydrogen phosphate (3.7 x 105), chloride (2.9 x 105), and nitrate (1.0 x 105).(18) 
 
1.3 Membrane-spanning peptides 
A relatively new method for the transport of ions across lipid bilayers is the de-novo 
design of helical peptides.(19,20) Merrifield SPPS opened the door to the production of nearly an 
endless library of peptides that is limited by available building blocks and an experimenters’ 
imagination. Attempting to synthesize a novel peptide that will form a helix that will 
spontaneously insert into a cellular membrane requires attention to several factors such as 
Figure 1.6: The pseudo-lipid, diarylacetylene fluorophore designed by 
Jessen et. al. to spontaneously incorporate into a synthetic lipid bilayer. 
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residue sequence, polarity, length of peptide, and efficiency of synthesis (not all sequences are 
created equal).(19,20) When a peptide interacts with the interior, non-polar portion of a lipid 
bilayer, it must conceal the backbone groups capable of hydrogen bonding. In order to do this, 
transmembrane peptides must take on secondary structure, the most common of which is an 
alpha-helix. With the backbone of a helix stabilized the next consideration is the many residue 
sidechains that radiate outwards from the central axis of the helical tube. The amino acid residues 
of a transmembrane peptide, especially those that interact with the non-polar interior of a lipid 
bilayer, must be made-up of mostly non-polar residues. When deciding which residues should be 
used to cap the N and C terminus of a novel peptide it is recommenced that aromatic residues are 
used at the interface between the non-polar lipid tails and polar head groups of a bilayer; polar 
residues are used for those directly interacting with the head groups or solvent.(21)  
Dr. Krishna Kumar at Tufts University has worked on 
producing transmembrane α-helical peptides that will 
spontaneously form dimer and tetramer bundles. This was 
done by transforming natural leucine residues into hexa-
fluorinated leucine.(22) The novel peptide, studded with newly 
fluorinated residues, will form aggregates due to the unique 
propensity of poly-fluorinated substances to spontaneously 
associate. Dr. Kumar was able to control the size of the 
respective bundles by how often in the primary sequence a natural leucine was substituted with a 
hexa-fluorinated derivative. When Dr. Christian Anfinsen first demonstrated the reversible 
unfolding of ribonuclease A it became very apparent that tertiary structure is vitally linked to the 
primary sequence of a protein, Anfinsen’s dogma.(23) Alpha helices are often represented on a 
Figure 1.7: Example of an 
α-helical wheel diagram. 
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two dimensional plane using a flat representation known as a wheel diagram. One is represented 
in Figure 1.7. The wheel diagram provides a good representation of the fact that an alpha helix 
contains different sides or faces, and because of this property a researcher can control the 
characteristics of a face by substituting various residues at every full turn of the helix. Dr. Kumar 
did just this by placing all of his poly-fluorinated leucine residues at one face of the peptide. 
Dr. William Degrado’s research group at the University of California SF developed a 
transmembrane peptide that spontaneously formed a four-helix bundle and was capable of 
selectively transporting Zn2+ across a lipid bilayer, named ‘Rocker’.(24) The ‘Rocker’ peptide’s 
namesake stems from a rocking mechanism that occurs when one end of the peptide bundle 
initially binds to an atom of zinc (II). This causes the peptide collection to squeeze more closely 
together at one end while spreading apart at the opposite end of the bundle. As the zinc (II) atom 
travels across the lipid bilayer the peptide structure rocks to accommodate the movement of the 
cation. This eventually causes the the once spread apart end of the bundle to come closer 
together and the opposite, previously close end, to spread apart. The activity of this peptide was 
done by picking the specific amino acids that would form the faces of the transmembrane alpha 
helix. On one face, Side A, the peptide had several aromatic residues (tyrosine and 
phenylalanine), and on another face, Side C, contains several alanine residues. These specific 
residues allowed for the individual peptides to aggregate into the desired tetramer, as well as 
leaves space for the rocking mechanism to occur. As for the transporting mechanism, Dr. 
Degrado placed histidine, serine, and glutamic acid residues on the face, Side B, between sides A 
and C. The more polar residues were situated towards the center of the tetramer where a pore 
was formed with the suitable geometry for the coordination of a zinc (II) ion. 
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1.4 Peptide design and synthesis 
In general, proteins are necessarily complex in order to support their many functions that 
give rise to the many diverse living organisms that exist. Despite these intricacies, scientists are 
determined to better understand the relationship between a protein’s structure and mechanism of 
action. The development of techniques like structural genomics and computational modeling 
have helped to expedite the process of structural elucidation.(25) The mechanism of protein 
function has been determined by these same techniques and many others, including solid phase 
peptide synthesis. Solid phase peptide synthesis (SPPS), developed by Robert Bruce Merrifield, 
has provided a method for rapidly synthesizing small physical portions of a protein in question.  
SPPS is useful for building small 6-40 residue peptides using theoretically any imaginable 
sequence of available amino acids.  The polymerization occurs via an orchestrated exchange of 
terminal amine deprotection and amide bond formation (Scheme 1.1).  SPPS is limited by 
several factors, including but not limited to: amino acid deletions and duplications, diminishing 
synthetic efficiency, the availability of building blocks, and cost. The most common type of 
automated peptide synthesizers rely on so-called “Fmoc chemistry,” in which the N atoms of the 
individual amino acid building blocks have been protected with 9-fluorenylmethoxycarbonyl 
(fmoc) groups (Scheme 1.1). 
 
 
 
 
 
12 
 
Scheme 1.1, Fmoc-Solid Phase Peptide Synthesis: A total representation of the 
sequence of steps that leads to the coupling of sequential amino acids in Fmoc-based solid phase 
peptide synthesis. (1) A polystyrene bead or resin with a methylbenzhydrylamine (MBHA) 
functional group is available for the coupling of the first amino acid. Note that the amino acids 
are protected on the backbone amino group in order to avoid unwanted multiple couplings of the 
same residue. (2) The first amino acid is activated on the free carboxylic acid to provide a better 
electrophile for amide bond formation. In this case N,N,N′,N′-Tetramethyl-O-(1H-benzotriazol-1-
yl)uronium hexafluorophosphate (HBTU) is shown. (3) The first amide bond was formed and 
now the fmoc protecting group must be removed for coupling of the next residue. (4) The use of 
a secondary amine (piperidine is shown) is used to absorb the most acidic proton and initiate the 
cleavage of the fmoc protecting group. (5) The loss of the proton at the 9 position on fmoc 
causes the protecting group to kick off as an alkene. (6) The remaining carbamate on the amino 
acid falls apart as a free amine through the loss of carbon dioxide. (7) The next amino acid is 
activated on the carboxylic acid with HBTU for amide bond formation. (8) The coupling is 
complete and the cycle continues for the next residue. 
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Scheme 1.1, Fmoc-Solid Phase Peptide Synthesis: (continued.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Another manner of studying proteins is to couple a fluorophore to the macromolecule.  
Small organic molecules that fluoresce can be used to do many things: allow an associated 
molecule to be tracked, the structural integrity of a molecule in vitro and in vivo can be 
elucidated, and the binding properties of a peptide can be quantitatively determined using 
fluorescence titrations. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
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1.5 Fluorescent Probes and Sensors 
 Fluorescence is a powerful technique for visualizing what occurs on the nearly invisible 
inner workings of a cellular microenvironment.  A huge part of current biotechnology deals with 
development of fluorescent tags or markers for enzymes, bacteria, and cancerous tissue.(26,27,28)  
The incorporation of fluorescent markers into synthetic peptides using SPPS has allowed 
researchers to track the whereabouts and final destination of small proteins in living 
organisms.(29,30)  Enzymatic mechanisms have also been elucidated using responsive fluorescent 
markers.(31) 
 The use of fluorescent probes has revolutionized the way scientists test the structural 
integrity of small peptides and proteins. The amino acids phenylalanine, tyrosine, and tryptophan 
all have intrinsic 
absorptive and 
fluorescent 
spectroscopic 
properties.(32) It is 
common for the 
unknown 
concentration of pure 
peptide in solution to 
be determined through 
an absorbance value along with the use of the Beer’s law equation and a standard molar 
absorptivity. The molar absorptivity for tyrosine, phenylalanine, and tryptophan can all be found 
as standard values in specific solutions.(32) A group at the University of Pennsylvania synthesized 
Figure 1.8: (1) 7-methoxycoumarin-4-ylalanine (λex=325 nm, λem=393 nm) and 
(2) acridon-2-ylalanine (λex=386 nm, λem=446 nm); all in phosphate buffer. 
(1) (2) 
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a set of fluorescent amino acids, 1.1 and 2.2 (Figure 1.8), that are quenched when in spatial 
association with an amino acid whose oxo-amide backbone has been replaced with a 
thioamide.(29) This means the group was able to engineer a series of small peptides in which the 
spatial significance to the novel chromophore of adjacent amino acids, modified to have a 
thioamide backbone, could be indirectly measured using fluorescence spectroscopy. The group 
used villin, a tissue specific actin binding protein that has been thoroughly characterized,(33,34) to 
provide evidence of a proof of concept model through temperature denaturation experiments. 
When the peptide was completely folded the fluorescent residue and thioamide residue were 
close together effectively quenching the fluorophore, and when the protein denatured, the 
emission signal increased. 
The Martin group at the University of Utrecht in the Netherlands also synthesized a 
fluorescent amino acid, L-(7-hydroxycoumarin-4-yl)ethylglycine, 1.3, and through protection of 
the α-N with 9-fluorenylmethyloxycarbonyl the product could be used on an automated solid 
phase peptide synthesizer, Figure 1.9.(30) They 
produced three different analogues of Leu-
Enkephalin, a commonly used model peptide 
due to size and ease of preparation via SPPS. 
After successfully providing a model for a 
proof-of-concept with the production of the 
fluorescent Leu-Enkephalin derivatives the 
group moved on to produce a fluorescent 
analogues of the HIV-tat48-60 peptide. It is well 
established that this peptide has significant implications in the ability of the HIV virus to infect 
Figure 1.9: (1.3) N-Fmoc-L-(7-hydroxycoumarin-4-
yl) ethylglycine (7-HC) 
(3) 
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cells. The truncated, arginine rich region of the peptide, residues 48-60, is capable of crossing 
membranes and thus can be used to deliver molecular cargo into cells. The Martin group was 
successful in producing HIV-tat48-60 with the fluorescent amino acid both at the C-terminus and 
in the middle of the peptide. Confocal microscopy was used on HeLa cells that were incubated 
with the fluorescent HIV-tat derivatives. The cells showed evidence of significant peptide uptake 
even with the addition of the larger unnatural amino acid. 
Quenching or spectral shifts are properties of a fluorophore that can be measured and 
quantified into meaningful data.(35) These properties are most often manipulated via solvent 
polarities or the presence of ions.(36)  The emission spectrum of a fluorescent compound will 
change with respect to its surroundings.  For example, the fluorescence of 2-anilinonaphthalene 
will change significantly with a change from pure cyclohexane to a 0.2% concentration of 
ethanol in cyclohexane,(37) and at 3.0% or greater ethanol the emission spectrum changes very 
little. This high sensitivity is what makes fluorophores so useful for determining the conditions 
of previously inaccessible microenvironments, and one microenvironment in particular that 
seems to always be of great interest is the cellular membrane. The compound 1-
pyrenehexadecanoic acid has been used since 1987 to determine the extent of water penetration 
into the hydrocarbon region of lipid bilayers.(37)  This works because when the fluorophore is 
found in the nonpolar, hydrocarbon region of the bilayer it exhibits one type of emission 
spectrum, and when water penetrates into the nonpolar region the microenvironment of 1-
pyrenehexadecanoic acid changes, and thus causes a change in the emission spectrum. 
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Compound 1.4, developed by Brooks et. al. 
uses a combination of urea and amide hydrogen bond 
donors in a cyclic design to form a pocket for anion 
binding.(38) The group performs multiple experiments 
to test the solvent effects on the ability for anion 
binding. The association constants of 1.4 are analyzed 
using 1H-NMR and the proton shifts that occur when 
those protons are shared between their respective 
nitrogen and the anion. Table 1.1 gives a collective 
representation of the association constants the group calculated. These results provide 
information about a few things. Compound 1.4 is much better at binding to carboxylate anions 
than it is to the other inorganic anions. The results also show how effective a small change in the 
amount of hydrogen bonding solvent present in the solvent can affect the ability for probe + 
anion complex to form. If a probe or sensor is based around the ability to form hydrogen bonds, 
then solvation effects are a significant matter that should be accounted for in an experiment. 
 
 
 
 
 
 
Figure 1.10: (1.4) A urea and multi-amide 
anion binder synthesized by Brooks et. al. 
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Table 1.1: The table provides the association constants for compound 1.4 with several anions 
using 1H-NMR in DMSO-d6 solutions containing different amounts of water. Generally, as the 
concentration of water increases the stability for the isolated anion is increased and does not bind 
as well. 
 Association Constants (M-1) 
Anion 
(tetrabutylammonium salts) 
DMSO-d6-0.5% water DMSO-d6-5.0% water 
Cl- 194 42 
Br- 10 - 
HSO4- 115 - 
H2PO4- 142 51 
NO3- <10 - 
CH3CO2- 16500 5170 
C6H5CO2- 6430 1830 
 
The design of small organic and supramolecular structures with the ability to sense 
anions is a constantly evolving area of supramolecular chemistry. The chelation abilities and 
anion sensing of these fluorophores 
are facilitated through the common 
motifs: amides, ureas, thioureas, 
pyrroles, indoles, and 
triazoles.(7,10,18,38-40) It is believed 
that this occurs through hydrogen 
bonding between the anion and the 
most electropositive hydrogen 
within each of these functional 
groups.  An example of the 
Figure 1.11: A representation of the resonance found in a 
single urea functional group and how this leads to a relatively 
acidic proton and efficient hydrogen bond donor. 
Figure 1.12: (1.5) N,N-dinaphthalimido urea 
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hydrogen bonding ability in a urea is given in Figure 1.11. 
 Fluorescent compounds are commonly used for the sensing of chloride, dihydrogen 
phosphate, fluoride, acetate, and bicarbonate. These particular anions are of great interest due to 
their relevance with medicine, food, biological systems and environmental remediation.(12) The 
most commonly used moiety for the production of neutral anion receptors is the urea functional 
group.(1,7,18,35,38,40-42) The Fabbrizzi group at the University of Pavia, Italy have expanded on the 
production of ureido-dimers, some of which have resulted in interesting colorimetric tests with 
fluoride through deprotonation.(35) In DMSO, addition of 1-5 equivalents of fluoride would 
deprotonate compound 1.5 (Figure 1.12) at one 
of the ureido N-H’s, producing a vivid red 
color, and upon addition of greater than 10 
equivalents the solution would take on a dark 
blue color. Their di-aryl urea groups also 
showed promise as colorimetric indicators for hydroxide, acetate, and dihydrogen phosphate. It 
was discovered that the association constant for dihydrogen phosphate and compound 1.6 
(Figure 1.13) was 6.3 x 104.(42) Other association constants with phosphate are represented in 
Table 1.2. 
Table 1.2: Reference table of several H2PO4
- receptors and their Kassoc values. 
Reference DMSO-0.5% H20 ACN CH2Cl2 (DCM) 
(38) 142   
(40) # 2 >104   
(40) # 4 523   
(41)  2344  
(42)  6.3 x 104  
(18) # 3   1.2 x 104 
(18) # 4   3.7 x 105 
 
Figure 1.13: (1.6) N,N-dipyridino 
urea 
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1.6 Conclusion 
Synthetic peptides represent a flexible platform for tissue and pathology-directed 
pharmacological design. As those peptides become more and more complex, the ability to 
accurately examine, manipulate, and functionalize designer peptides will be a flourishing area of 
research. The following chapters describe efforts to combine peptide scaffolds with fluorescent 
labels, allowing membrane incorporation and ion-transport function to be conveniently 
monitored. Synthesizing a library of fluorescent, anion responsive, protected amino acids that 
can be successfully incorporated into a peptide sequence via SPPS opens the door for use in 
multiple biotechnological fields. 
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CHAPTER 2: SYNTHESIS OF ANION SENSING FMOC-PROTECTED AMINO ACIDS 
2.1 Results and Discussion 
2.1.1 Introduction 
 This chapter describes the preparation and spectroscopic behavior of fluorescent non-
natural amino acids that are environmentally sensitive, capable of binding specific anions, and 
can be successfully incorporated into designer synthetic peptides. The non-natural amino acids 
2.1 and 2.2 (Figure 2.1) were successfully synthesized from commercially available (S)-4-(((9H-
fluoren-9-yl)methoxy)carbonylamino)-5-tert-butoxy-5-oxopentanoic acid (Fmoc-Glu-OtBu) and 
(S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-tert-butoxy-4-oxobutanoic acid (Fmoc-
Asp-OtBu). The fluorescent products 2.1 and 2.2 were evaluated for their response to titration 
with various biologically relevant anions and their ability to be inserted into peptides using 
standard solid phase synthesis protocols. 
 
Figure 2.1: (a)(compound 2.1) (S)-tert-butyl 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(3-(2-butyl-1,3-
dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)ureido)butanoate (b)(compound 2.2) (S)-tert-butyl 2-(((9H-
fluoren-9-yl)methoxy)carbonylamino)-3-(3-(2-butyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-
yl)ureido)propanoate 
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2.1.2 Design and Synthesis 
The non-natural amino acids 2.1 and 2.2 were chosen because they feature a urea group, 
which is a potential anion-recognition site, and a naphthalimide fluorophore, which has been 
shown to be bright and sensitive to its local micro-environment.(43,44) We recognized that reaction 
of a 4-aminonaphthalimide with an isocyanate (-N=C=O) would produce a urea with a directly-
attached fluorescent reporter unit. 
Synthesis of the requisite naphthalimide fluorophore was accomplished in a manner first 
developed by Triboni et. al. (Scheme 2.1).(46) Commercially available 4-nitro-1,8-naphthalic 
anhydride was mixed in a 250 ml Erlenmeyer flask along with 150 mL of distilled water and 
about 7 equivalents of n-butylamine. The reaction mixture was sonicated using a 50-60 mHz 
bath for 90 minutes or until all of the floating solid anhydride had suspended below the water 
surface. The mixture was then filtered through a fine frit glass funnel giving a 95% yield of crude 
solid after thoroughly drying on a high vacuum line to ensure removal of all remaining water. 
The solid N-butyl-4-nitro-1,8-naphthalimide was then placed in a Parr reaction bottle along with 
200 mL anhydrous ethanol and 5 mole percent of 10% palladium on carbon catalyst. The 
reaction bottle was inserted into a hydrogenation apparatus, charged with 30 psi of hydrogen gas, 
and then shaken for 90 minutes or until all of the fluorophore had gone into solution. The amino-
containing product is soluble in ethanol while the nitro compound is largely insoluble in ethanol. 
The catalyst was filtered off through two sheets of filter paper, and the filtrate evaporated to 
remove the organic solvent. The solid was then dissolved into a mixture of dichloromethane and 
methanol (9:1) and purified on a silica column via flash chromatography. The green band, easily 
identifiable with use of a 365 nm light bar, was collected and evaporated. Hydrogenation 
routinely gave a 65% overall yield for the production of 4-amino-N-butyl-1,8-naphthalimide, 2.3.  
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Scheme 2.1: Synthesis of N-butyl-4-aminonaphthalimide fluorophore. 
 
 
 
 
 
The fluorescent amino acids 2.1 and 2.2 were synthesized from glutamic and aspartic 
acids that are available commercially with N- and O-protecting groups already in place (as Fmoc 
and t-butyl, respectively). A purchased Fmoc-(AA)-OtBu was first dissolved in tetrahydrofuran 
(THF) along with one equivalent of N-methylmorpholine and the flask chilled in an ice-salt bath 
(Scheme 2.2). Once the contents had reached -15 ˚C, one equivalent of ethyl chloroformate was 
slowly introduced into the mixture. After stirring for 20 minutes, 1.5 equivalents of aqueous 
sodium azide was added as a solution in a minimal amount of water. The mixture was stirred in 
the ice for 30 minutes and then allowed to warm. Once the reaction mixture reached room 
temperature the organic solvent was removed in vacuo and the solid residue was dissolved in 
dichloromethane. The organic phase was washed three times each with 5% hydrochloric acid, 
5% aqueous sodium bicarbonate, and water. The dichloromethane was dried with anhydrous 
sodium sulfate and then removed by rotary evaporation to yield an off-white foamy solid in ~90 
% yield. 
The next step was to convert the acid azide into an isocyanate via the Curtis 
rearrangement.(45) This was done by heating the acid azide to reflux in dry toluene. The acid 
2.3 
62 % 
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azide was first placed in a round-bottomed flask with the minimum amount of toluene needed to 
achieve dissolution, and 2.0 equivalents of 2.3. The amino fluorophore was introduced before 
heating commenced to ensure that it would be present to trap any isocyanate as it formed in situ. 
After the reaction mixture had stirred for 48 hours at reflux the toluene was removed via rotary 
evaporation to yield a viscous, brown liquid. The crude product was dissolved in 
dichloromethane and methanol (19:1, v/v) and loaded onto a silica gel column for purification 
via flash chromatography. (The product is most easily identifiable as the first fluorescent blue 
band under 365 nm light. The green band that elutes later is the naphthalimide fluorophore that 
did not couple to an isocyanate; it can be collected for recycling and for calculation of yield 
“based on recovered starting material” (BRSM)). The collected blue band was evaporated to 
remove solvent and then dissolved in acetonitrile and water (3:1) for purification by HPLC. The 
product peak was collected and lyophilized for use in fluorescence studies and peptide synthesis. 
Analytical samples of compounds 2.1 and 2.2 can also be purified without the use of an HPLC 
through recrystallization with acetonitrile as the solvent. 
Before the newly synthesized amino acids could be used for solid phase peptide 
synthesis, the t-butyl protecting groups had to be removed to open the carboxylic acid to amide 
bond formation. However, the t-butyl protecting groups were retained throughout the 
fluorescence studies in order to model an amino acid structure with the carboxyl group restricted 
as in a peptide; also, carboxylate is an anion of interest and the retention of the t-butyl ester was 
necessary to avoid interfering with anion binding results. It is important to note that peptide 
sequences containing aspartic or glutamic acids may hinder an accurate measurement with 2.1 
and 2.2. To convert the t-butyl ester into a carboxylic acid compounds 2.1 and 2.2 are dissolved 
into a cocktail of 70% trifluoroacetic acid, 20% methylene chloride, 5% triethylsilane, and 5% 
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anisole (all by volume). The mixture was allowed to cleave for 3 hours, with stirring under 
nitrogen, before the solvent was removed in vacuo. Finally, the carboxylic acids 2.4 and 2.5 were 
purified via HPLC or through trituration of the residue with anhydrous ethanol. The solid 
remaining in the flask after trituration was pure product, as judged by TLC. 
Scheme 2.2: Synthesis of fmoc-protected, fluorescent naphthalimido-urea containing amino 
acids 2.1 and 2.2. 
 
  
 
 
 
26 
 
2.1.3 UV/vis and Fluorescence Results 
The spectrophotometric properties of fluorophore 2.2 were analyzed to get benchmark 
values before fluorescence titrations with anion guests could be performed. Compound 2.2 was 
dissolved in three solvents: dichloromethane, acetonitrile, and H2O-DMSO (50:1), and its 
electronic absorption maximum, extinction coefficient, and emission wavelength were 
determined (Table 1). Compound 2.1 was used to obtain fluorescence quantum yields in 1-
octanol and acetonitrile (Table 2). 
 
Figure 2.2: (a) UV/vis spectra of 2.2 (6.23×10-5 M) in three solvents with a range of polarities: dichloromethane 
(red λmax= 370 nm), acetonitrile (green λmax= 372 nm), water:DMSO (50:1) (blue λmax= 381 nm). (b) Comparison of 
the change in fluorescence emission when 2.2 (8.90 × 10-6 M) was dissolved in the three solvents dichloromethane 
(red λem= 441 nm), acetonitrile (green λem= 451 nm), water:DMSO (50:1) (blue λem= 482 nm) and excited at the λmax 
when dissolved in the respective solvent. 
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Table 2.1: UV/vis properties of 2.2 in three solvents of varying dielectric constants: 
dichloromethane (9.08), acetonitrile (36.64), water-DMSO (78.54).a ε = molar absorptivity 
SOLVENT Absorbance (nm) ε (M-1 cm-1) emission (nm) 
CH2CL2 370 9250 441 
CH3CN 372 10600 451 
H2O-DMSO (50:1) 381 6800 482 
a The dielectric constant is that of pure water. 
Table 2.2: Fluorescence properties of 2.1 in 1-octanol and acetonitrile. Φ = quantum yield 
SOLVENT Absorbance (nm) Φ emission (nm) 
1-OCTANOL 390 0.48 468 
CH3CN 390 0.54 463 
 
Compound 2.1 was initially dissolved in 1-octanol to perform fluorescence titration 
experiments. The sample cuvette was inserted into a fluorometer with excitation wavelength set 
to 390 nm. An emission scan from 400 – 650 nm was acquired, with the maximum found to be 
468 nm. A solution containing Cl- as potential anionic guest (from tetrabutylammonium chloride; 
66.7 mg/50 mL 1-octanol), was introduced into the cuvette at known aliquots and the 
fluorescence scans were repeated. Upon initial observation there was no appreciable quenching 
of the fluorescence during this experiment. A more basic anion, HCO3
-, was tested (from 
tetraethylammonium bicarbonate; 21.4 mg/50 mL), and again little to no response was observed. 
As per good scientific technique, an additional solvent was chosen to repeat the experiment. 
Fluorophore 2.1 was dissolved in acetonitrile and the fluorescence was recorded. The excitation 
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wavelength remained at 390 nm and the emission maximum was measured to be 463 nm with a 
base width from 400 to 650 nm. When the anion chloride was first introduced a small increase in 
fluorescence intensity was noted along with a red-shift in the emission wavelength to 470 nm. 
Upon addition of 8 equivalents of chloride the fluorescence began to quench (Figure 2.3). After 
addition of a significant excess of chloride the fluorescence intensity had only quenched by a net 
2.0 percent. The descending slope of the curve appeared to be linear and was fitted to a Stern-
Volmer quenching curve. This provided an association constant, KSV of 70 M
-1. Stern-Volmer 
curves are used to fit an association value to a host + guest complex that quenches the 
fluorescence based on the presence of other material in a solution. Stern-Volmer quenching is 
also known as collisional quenching because an excited fluorophore will release energy through 
other avenues than fluorescence, such as colliding with material in the solution. As the presence 
of other stuff in a solution increases the fluorescence is further quenched. 
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Figure 2.3: a) Fluorescence quenching curve of compound 2.1 from titration with tetrabutylammonium chloride 
hydrate in acetonitrile, and b) representative fluorescence spectra. 
The next anion tested was H2PO4
- (from tetrabutylammonium dihydrogenphosphate). The 
first aliquot of dihydrogenphosphate, while containing much less than 1 equivalent of the ion, 
quenched about 30% of the original integrated fluorescence (F0) of compound 2.1. Plots of F/F0 
vs [H2PO4
-]total were hyperbolic in shape, and ultimately about 90 % of the original fluorescence 
was quenched (Figure 2.4).  
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Figure 2.4: a) Fluorescence quenching curve of compound 2.1 from titration with tetrabutylammonium phosphate 
monobasic in acetonitrile and b) fluorescence spectra. 
When graphs of F/F0 vs. [anion]total have an “L”-shape, this is indicative of the 
fluorophore binding to the anionic species.(46) The λem of the fluorophore shifted from 463 nm to 
476 nm. This red shift of the fluorescence arises from weakening of the urea N–H bond(s) as 
they interact with an anion. The weakening of this bond allows electron density on N to increase, 
and the aromatic fluorophore to become more electron-rich. This electron richness brings the 
HOMO-LUMO molecular orbital energy levels closer together, resulting in less energy being 
emitted when the excited state fluorophore lowers to the ground state. The lower energy emitted 
as fluorescence is directly related to a longer wavelength or red-shift in the fluorescence 
emission. 
Another anionic species, bicarbonate, was tested next. The addition of increasing 
amounts of bicarbonate produced a fluorescence quenching curve with a sigmoidal shape, Figure 
2.5. This suggests that at this specific concentration the host fluorophore had begun to form 
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oligomers through what is known as urea stacking (another result from the resonance ability of 
urea). The initial slow decrease in the fluorescence was because the bicarbonate must first break 
apart the oligomers before it can bind to urea. When the concentration was lowered the 
quenching curve took on a typical hyperbolic 1:1 binding curve (seen in Figure 2.6). The 
addition of more bicarbonate stopped having a significant effect after 80% of the fluorescence 
intensity had been quenched.  
 
Figure 2.5: a) Fluorescence quenching curve of compound 2.1 from titration with tetraethylammonium bicarbonate 
in acetonitrile and b) the fluorescence spectra. 
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Figure 2.6: a) Fluorescence quenching curve of compound 2.1 from titration with tetraethylammonium bicarbonate 
in acetonitrile at a lower concentration than the host solution used in Figure 2.5 and b) the fluorescence spectra. 
 
The λem of the fluorophore shifted from 463 nm to 494 nm. This significant red shift in 
the maximum wavelength of the fluorescence is evidence of the removal of the hydrogen from 
the aromatic nitrogen in the urea group. The removal of a hydrogen results in a full negative 
charge on the aromatic nitrogen.(35) Again, the negative charge gives a more electron rich 
fluorophore and thus a lower HOMO-LUMO energy gap. 
Finally, the anion nitrate was titrated into a solution of compound 2.1. Upon addition of a 
large excess of tetrabutylammonium nitrate the quenching appeared to be linear. This is known 
as collisional quenching and is best represented with a Stern-Volmer plot, KSV was found to be 
69 ± 3 M-1.  
(a) (b) 
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Figure 2.7: a) Fluorescence quenching curve of compound 2.1 from titration with tetrabutylammonium nitrate in 
acetonitrile and b) the fluorescence spectra.  
The association constants, Kassoc, for compound 2.1 and
 H2PO4
- were derived from the 
fluorescence titrations by fitting a line to the graph of the ratio of integrated fluorescence (F) to 
initial integrated fluorescence (F0) vs the concentration of the anion; for 2.1 + bicarbonate Kassoc 
was found through fitting a line to the graph of F/F0 vs. log[HCO3
-]. The Kassoc for compound 2.1 
with phosphate and bicarbonate were found to be 20151 ± 915 M-1 and 39881 ± 1475 M-1, 
respectively. 
Fluorescence titrations were repeated for compound 2.2 using dihydrogenphosphate, 
chloride, and bicarbonate. Some interesting trends developed from using compound 2.2 versus 
2.1. Notably, compound 2.2 appeared to bind to the anions much more tightly than compound 
2.1. After graphing the fluorescence quenching and fitting a curve to the data, Kassoc could be 
calculated. For 2.2 + H2PO4 the association constant was found to be 2.6  104 ± 1.2  103 M-1.  
 
 
(b) (a) 
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Figure 2.8: a) Fluorescence quenching curve of compound 2.2 from titration with tetrabutylammonium phosphate 
monobasic in acetonitrile and b) the fluorescence spectra. 
The fluorescence response from titration with bicarbonate gave an L-shape. This further 
supports the theory that a higher concentration of the fluorescent amino acids may in fact cause 
urea stacking since titrations with compound 2.2 were performed at lower concentrations of host. 
However, titrations on compound 2.2 were performed multiple times and each time the 
calculated association constant was different than the last. The Kassoc was found to range from 6.2 
× 104 to 2.8 × 105 M-1. While the data results achieved were unreliable it does suggest that the 
association constant for 2.2 and HCO3
- is >1.0 × 105 M-1. Fluorescence titrations were also 
performed on 2.2 using tetrabutylammonium chloride. Again, the titration caused the 
fluorescence to increase slightly (also causing a slight red shift in the emission band) before 
causing the fluorescence to quench a net 30 %. This was only achieved after greater than a 2000-
fold excess of guest had been added. Again, the descending portion of the curve appeared to have 
a linear relationship and when a Stern-Volmer quenching curve was fitted to this data it gave a 
KSV = 70 M
-1 (Figure 2.9). 
(a) (b) 
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Figure 2.9: a) Fluorescence quenching curve of compound 2.2 from titration with tetrabutylammonium chloride in 
acetonitrile and b) the fluorescence spectra. 
 
Figure 2.10: Stern-Volmer quenching curve of compound 2.2 from titration with tetrabutylammonium chloride in 
acetonitrile. 
(a) (b) 
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Particularly for the Glu derivative 2.1, when certain anions were introduced a change in 
the visible color of the solution was observed. While H2PO4
- would cause the solutions to change 
from colorless to a light/dark yellow, HCO3
- (and other relatively basic species, when in 
acetonitrile, like F- and CH3COO
-) would cause the solution to change to a dark orange or red. It 
was hypothesized that the dark orange or red was a result from deprotonation of the 
fluorophore(35) at the most acidic proton, the aryl N-H urea proton. To test this hypothesis with 
Asp derivative 2.2, a solution in acetonitrile (6.0  10-6 M) was prepared in a cuvette and 
increasing amounts of anion were added. The UV/vis spectrum of the compound was taken to 
look for a shift in the absorbance of visible light. No deprotonation could be detected by UV/vis 
when 55 equivalents of tetraethylammonium bicarbonate were present. Only after a large excess 
of solid tetraethylammonium bicarbonate was added to the cuvette was the λmax observed to shift 
(to 388 nm) while a new, lower-energy peak appeared (at 467 nm). When the same sample was 
inserted in a fluorometer and excited at 388 nm the fluorescence emission band was seen at 463 
nm as in Figure 2.11. When the system was excited at 467 nm, an emission band was observed at 
569 nm with an intensity about 10% of the 463 nm feature. The same series of experiments were 
performed using tetrabutylammonium dihydrogenphosphate in a fresh cuvette of the same 
solution of fluorophore 2.2. By UV/vis, after addition of a large amount of anion the λmax shifted 
from 369 nm to 376 nm and another peak became apparent at 475 nm. Results of fluorescence 
measurements are shown in Figure 2.12. These qualitative tests prompted a qualitative 
experiment to see how the fluorophores would behave when treated with a series of anions; this 
could open a door for use as a fast colorimetric indicator for selected biologically and 
environmentally relevant anions.  
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Figure 2.11: (a) UV/vis spectra of Fmoc-Asp*-OtBu (2.2) in acetonitrile before (371 nm) and after (388 nm and 467 
nm) the addition of a large excess of solid tetraethylammonium bicarbonate. (b) Emission spectra of Fmoc-Asp*-
OtBu excited at 388 nm (red annotation) and 467 nm (green annotation). 
 
 
λmax = 371 nm 
λmax = 388 nm 
λmax = 467 nm 
λem = 569 nm 
λem = 463 nm 
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Figure 2.12: (a) UV/vis spectra of Fmoc-Asp*-OtBu (2.2) in acetonitrile before (369 nm) and after (376 nm and 475 
nm) addition of a large excess of solid tetrabutylammonium dihydrogenphosphate. (b) Emission spectra of Fmoc-
Asp*-OtBu when excited at 376 nm (red annotation) and 475 nm (green annotation). 
 
A colorimetric experiment was performed using compound 2.1 to observe qualitative 
changes in the visible color and fluorescence when a variety of anions were added to the 
solution. The anions tested were: chloride, tosylate, nitrate, dihydrogen phosphate, fluoride, 
azide, acetate, and bicarbonate. The anions are listed in order of increasing basicity in aqueous 
solution. It is important to note that this test was performed in acetonitrile and the relative 
basicity of these anions is likely different than that in water due to a change in the stability of the 
conjugate base. Concerning the color changes seen in Figures 2.13, the response by the 
fluorophore does not track predictably with increasing pKb. 
λmax = 369 nm 
λmax = 376 nm 
λmax = 475 nm 
λem = 454 nm 
λem = 561 nm 
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Figure 2.13: (a & b) Change in the visible color of acetonitrile solutions of 2.1 after the addition of one equivalent 
of respective anion. The cuvettes are organized in order of increasing aqueous pKb of the added anion. (c) The 
fluorescence response from a solution containing compound 2.1 and one equivalent of the respective anion. Little 
change was observed with further addition of 2 and 3 equivalents of analyte. 
 
Increasing basicity 
(a) 
(b) 
(c) 
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Table 2.3: Relative pKb values of the anions added to the cuvettes in Figure 2.13. 
ANION pKB IN H2O pKA IN ACETONITRILE 
CHLORIDE 21 5.1 
TOLSYLATE 16.8 5.6 
NITRATE 15.4 5.2 
DIHYDROGENPHOSPHATE 11.9 - 
FLUORIDE 10.8 - 
AZIDE 9.4 - 
ACETATE 9.2 -9.5 
BICARBONATE 7.7 - 
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2.1.4 1H-NMR Titration 
Proton NMR was used to monitor chemical shifts of compound 2.1 in DMSO-d6 (6.9 
mM) while a solution of tetrabutylammonium dihydrogenphosphate (47 mM) was added. A 
significant downfield shift in the urea proton peaks was observed over the course of 9 additions 
of phosphate. The most fascinating aspect is that the peaks for the urea protons did not begin to 
shift until more than 1 equivalent of 
anion had been added to the solution. 
The shift in the proton peaks is 
represented in Figure 2.15. It was 
hypothesized that intramolecular 
hydrogen bonding occurs which 
initially limits the ability for the urea 
receptor to bind to phosphate. Also, it 
has been shown that when urea 
containing molecules are in high 
concentrations intermolecular urea 
stacking may occur and initially limit 
the ability for hydrogen bonding.(18) While the evidence suggests that the phosphate is not 
binding to the urea moiety before one equivalent is reached, the anion may still able to associate 
with 2.1 elsewhere on the molecule, but most likely may need to dissociate oligomers formed 
when the fluorophore is in solution at high concentrations. 
Figure 2.14: Structure of 
compound 2.1 with the urea 
protons designated as Ha 
and Hb for use to clarify the 
assignment of the shifts in 
the 1H-NMR titration 
provided in Figure 2.13. 
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Ha 
Hb 
Figure 2.15: Representation of the proton shifts of Ha and Hb during titration of 2.1 with dihydrogenphosphate 
in DMSO-d6. 
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A 1H-NMR titration was performed on compound 2.2 as well. The titration was 
performed in DMSO-d6 at 3.6 mM 2.2 with tetrabutylammonium dihydrogenphosphate at a 
concentration of 5.2  10-2 M-1. The urea N-H peaks for compound 2.2 began to move at the first 
addition of phosphate anion. Two plots representing the ppm shift of the urea aryl N-H proton vs 
[H2PO4
-] added are presented in Figure 2.16. A plot of the ppm shift for the urea alkyl N-H 
proton vs [Cl-] added is also represented in Figure 2.17. The use of aryl vs. alkyl was chosen 
based on which proton was seen to give the largest shift in ppm. Plotting of this specific data 
would provide the most accurate association constant. Using the plotting program WinEQNMR 
the association constants for compound 2.2 + H2PO4
- and 2.2 + Cl- were found to be 1300 ± 77 
M-1 and 19 ± 5 M-1, respectively.(47) 
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Figure 2.16: Graphical representation of the ppm shift in the aryl N-H urea proton during NMR titration of 2.2 with 
tetrabutylammonium dihydrogenphosphate. The WinEQNMR program was used to fit an NMR binding curve to the 
data. Kassoc = 1300 ± 77 M-1. The small graph at the top is simply a representation of how well the relative data point 
falls on the fitted curve. The closer the value is to zero the closer it is to the fitted line. This provides support that the 
WinEQNMR program supplied a proper fit. 
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Figure 2.17: Graphical representation of the ppm shift in the alkyl N-H urea proton during NMR titration of 2.1 
with tetrabutylammonium chloride hydrate. The WinEQNMR program was used to fit an NMR binding curve to the 
data. Kassoc = 19 ± 5 M-1. The small graph at the top is simply a representation of how well the relative data point 
falls on the fitted curve. The closer the value is to zero the closer it is to the fitted line. This provides support that the 
WinEQNMR program supplied a proper fit. 
 
2.1.5 Discussion 
 When chloride and bicarbonate were introduced into solutions of compound 2.1 in 1-
octanol, no fluorescence quenching occurred. The design of compound 2.1 and 2.2 was chosen 
because hydrogen bonding between the anions and the urea group was expected to cause a 
change to the immediately bonded fluorophore. Since 1-octanol has the ability to hydrogen bond, 
it was probably interfering with the ability of the anion to come into contact with the urea.(48) The 
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1-octanol was replaced with a solvent without H-bond donor ability, acetonitrile. Upon addition 
of the analyte ions, changes in fluorescence were observed. All subsequent fluorescence 
titrations were performed in this solvent. Titrations were repeated three times each and the peak 
areas under the curve were collected to give a value directly proportional to the total number of 
photons emitted by the excited fluorophore. Graphs were made to display the change in the area 
under the curves (F/F0) versus the [anion]. A few examples of these curves are represented in 
Figures 2.3-2.8 and the rest are provided in Appendix A. 
For Glu derivative 2.1, addition of chloride initially brings about a small (6%) increase in 
the fluorescence intensity (Figure 2.5). This behavior is consistent with a process that replaces 
relatively strong urea H-bonds (within the host molecule itself) with relatively weaker ones (to 
Cl-). The NMR behavior of 2.1, in which no shifting of the N-H resonances was observed until 
>1 equiv of anion was present, can thus be rationalized: intramolecular NHO interactions in 
2.1 are retained until sufficient anion is present to drive “unfolding” of the host. The same result 
is witnessed in 2.2 plus Cl-, about a 4% increase in the fluorescence intensity before what 
appears to be a linear quenching of the fluorescence. For both amino acids, when the linear 
portion of the quenching curve is matched to a Stern-Volmer equation an association constant of 
70 M-1 is obtained. With the addition of tetrabutylammonium nitrate a linear decrease in the 
fluorescence was observed. Although the trigonal planar nitrate ion would seem to have an 
optimal shape for binding to the urea, as the conjugate base of a strong acid, it does not have the 
basicity needed to form a hydrogen bond with the urea protons and elicit a response. The linear 
behavior was fitted to give a Stern-Volmer quenching constant KSV of 69 ± 3 M
-1. This is 
significant because Stern-Volmer or collisional quenching should remain the same no matter 
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what species is introduced into the solution. For both 2.1 and 2.2, chloride and nitrate give a 
collisional quenching response. 
Upon addition of small aliquots of H2PO4
- solution there is an immediate 30% decrease in 
the fluorescence of 2.1, followed by continued 
quenching until saturation is observed. The 
hyperbolic curve obtained from this response is 
evidence of phosphate-urea binding (Figure 2.4). 
The average association constant, Kassoc, from the 
three titrations was found to be 20151 ± 915 M-1 
and the Kassoc for 2.2 was found to be 25600 ± 
1200 M-1. These values are comparable to those 
found for compounds 2.6 and 2.7, which report 
binding constants to dihydrogenphosphate in acetonitrile of 2300 and 63000 M-1, 
respectively.(22,23) The predicted orientation of the bound phosphate with 2.1 and 2.2 will be 
discussed in a later section. 
For bicarbonate ion, there was initially very little change in the fluorescence peak area, 
but as more bicarbonate was added to the solution the effect of the analyte became more 
pronounced. Once the integrated intensity of 2.1 had been quenched by about 80%, the addition 
of more bicarbonate caused no further change. The quenching curve took on a sigmoidal shape. 
After further consideration it was suspected that the sigmoidal shape was a result of the host 
molecule forming intermolecular oligomers through urea stacking. Before bicarbonate could 
bind to the urea and cause quenching the bicarbonate must break apart the intermolecular 
Figure 2.18: Structures of (a) compound 
2.6 and (b) compound 2.7. 
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stacking. A more dilute solution of host fluorophore yielded a hyperbolic, L-shaped curve as 
seen in Figure 2.6. 
Despite the small structural difference between amino acids 2.1 and 2.2, the latter binds 
to phosphate and bicarbonate much more robustly than the former. After further calculation the 
2.2 + H2PO4
- complex had a Kassoc value slightly greater than 2.1 + H2PO4
-. The differences 
continued to present themselves after titration of 2.2 with bicarbonate. When the titration data 
was plotted and fitted to a curve it took on a hyperbolic shape, that provided an association 
constant that was unable to accurately be measured; at least >1.0 × 105 M-1. 
The proton on the nitrogen of the urea closest to the aromatic ring is the most acidic in 
the molecule, and previous work has shown that basic anions are able to deprotonate ureas in 
polar aprotic solvents. In our case, the appearance of a dramatic orange color may have potential 
in colorimetric indication of pH. It may also be possible to use this to bracket the pKa range of 
the urea protons in a non-aqueous solvent like acetonitrile. 
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2.1.6 Computer Modeling 
 DFT optimizations were 
performed on compounds 2.1 and 2.2 
in a solvent dielectric corresponding 
to acetonitrile. It is important to note 
that the Fmoc group was truncated to 
a methyl unit for simplification. The 
calculated association energies 
(ΔEassoc) for phosphate binding to 
compounds 2.1 and 2.2 were found to 
be -31.1 and -36.8 kcal/mol, 
respectively. These results follow the 
trend in Kassoc values for 2.1 (2.1  
104 M-1) and 2.2 (2.5  104 M-1) obtained through fluorescence titrations. The computational 
results predict that Glu derivative 2.1 (Figure 2.19 (b)) forms only a pair of H-bonds at one 
phosphate oxygen. The bond distances were calculated to be 2.01 Å to the alkyl N-H and 1.93 Å 
to the aryl N-H. For compound 2.2 (Figure 2.19 (a)) it is predicted that phosphate has a multi-
point interaction through hydrogen bonding. Again, one oxygen from the phosphate is shared 
between the two urea protons (1.96 Å to the aryl N-H and 2.03 Å to the alkyl N-H), but also 
another phospho-oxygen is associated with the N-H from the backbone carbamate (1.99 Å to the 
amide N-H). One of the phosphate hydroxyls is predicted to hydrogen bond with the carbonyl 
oxygen found at the backbone t-butyl-ester (1.95 Å to the ester C=O). These unique results 
suggest that the Asp derivative produces a enzymatic-like pocket for the association with 
Figure 2.19: COSMO-DFT molecular structures in acetonitrile of 
(a) 2.2 and (b) 2.1 with a dihydrogenphosphate anion. black = C, 
blue = N, red = O, orange = P, white = H. 
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phosphate; while the glu derivative merely associates through direct, head-to-head association 
with the two ureido-protons and a single P=O. Simply put, the Asp derivative has the ability bind 
through more coordination sights and is expected to have a stronger binding ability. The 
computer models also agree with the 1H-NMR titration of compounds 2.1 and 2.2 with 
phosphate, which produces a shift in the alkyl urea protons of 1.58 ppm and 1.67 ppm and aryl 
urea protons of 1.85 ppm and 1.82 ppm, respectively (note that 1H-NMR titration of 2.1 was 
terminated after addition of 7.9 equivalents of anion, and the 1H-NMR titration of 2.2 was 
terminated after the addition of 3.8 equivalents of anion). 
The optimization for the binding of 2.1 to bicarbonate is not shown, however it produced 
an image similar to Figure 2.19(b), with exception that two separate oxygen atoms from the 
bicarbonate each associated with one of the ureido-protons through hydrogen bonding; 1.92 Å to 
the aryl N-H and 1.93 Å to the alkyl N-H . The relative association energies for 2.1 + H2PO4
- and 
2.1 + HCO3
- were provided through computer modeling and the trend in the association energies 
agrees with the results found through fluorescence titration. When 2.1 was titrated with 
tetrabutylammonium dihydrogenphosphate a fit line matched to the quenching curve provided a 
Kassoc of 2.0  104 M-1, and when 2.1 was titrated with tetraethylammonium bicarbonate the Kassoc 
was calculated to be 4.0 104 M-1. Although the difference in the energies was relatively small, 
the equilibrium constants found from the fluorescence titrations match the trend that would be 
predicted from the calculated association energies. 
2.1.7 Peptide Results and Discussion 
 Once the tert-butyl protecting groups were removed from the amino acids, they were 
used as reactants in solid-phase peptide synthesis to ensure that the products would behave in a 
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manner similar to commercially available Fmoc protected amino acids. Compound 2.4 was 
inserted into “Glu-peptide” YKKE*IAHALFSA-CONH2 (2.6) and compound 2.5 was inserted 
into “Asp-peptide” YKKEIAHALD*SA-CONH2 (2.7). These 12-mers were prepared by classic 
Merrifield solid phase peptide synthesis on Rink amide resin, at a 0.058 mM scale. The sequence 
chosen for the peptides was derived from the first 12 residues of a helical peptide named 
“Rocker” synthesized by the DeGrado group, YYKEIAHALFSALFALSELYIAVRY.(24) The 
“Rocker” peptide was found to spontaneously form a transmembrane alpha helix that transports 
zinc ions, and thus provided an ideal scaffold for the development of an anion transporting 
peptide. The original “Rocker” peptide was first truncated to the first 12 residues in order to 
provide an example for successful incorporation of the novel amino acid, as well as to test the 
ability for the new peptide to enter the interior of a lipid bilayer. The first change made to the 
original sequence was the exchange of the tyrosine (Y) at the second position for a lysine (K) 
residue to help increase water solubility. The second change made for the “Glu-peptide” was the 
exchange of the glutamic acid (E) for 2.4, as for “Asp-peptide the second change was the 
exchange of an aromatic phenylalanine (F) to compound 2.5.  
 Liposomes are used as a model to represent the lipid bilayer that acts as the 
barrier between what is outside of and inside a cell. Liposomes are made up of a spherical 
collection of individual lipid molecules that form two layers each with their polar head groups 
facing the aqueous solvent while the hydrocarbon tails aggregate inwards to form a relatively 
large non-polar layer. The liposomes used for the experiments performed here are made from the 
phospholipid 1-Palmitoyl-2-oleoylphosphatidylcholine or POPC. As shown in Figure 2.2(b) the 
fluorescence intensity and wavelength of compounds 2.1 and 2.2 can change significantly when 
compared in an organic solvent versus an aqueous solvent. This solvatochromism can be used to 
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determine if a fluorophore is capable of integrating with the non-polar region of a lipid bilayer in 
a buffer solution. The “Asp-peptide” was designed to give a peptide that would spontaneously 
insert into a lipid bilayer. The change in emission wavelength due to a change in surrounding 
polarity will provide evidence as to where the molecule is located. Likewise, the change in 
fluorescence intensity will be measured as various anions are titrated into the solution. If the 
“Asp-peptide” sits in the lipid bilayer as predicted any change in the fluorescence indicative of 
anion binding will be due to an anion localizing into the interior of the bilayer. 
The “Glu-peptide” was purified by HPLC as confirmed by mass spectroscopy and 1H-
NMR (see appendix B). While attempting to form liposomes with the “Glu-peptide” the model 
membranes failed to form and the small amount of purified peptide was lost.  
The “Asp-peptide” was formed using compound 2.5. Although there was a 68 % crude 
yield of peptide collected after it was cleaved from the resin only <1 mg of the recovered peptide 
consisted of the complete sequence and had successfully incorporated the new synthetic amino 
acid. With such a small amount of peptide recovered from HPLC an 1H-NMR was not able to be 
obtained; however, mass spectroscopy (MS) coupled with an HPLC spectra of a lone large peak 
absorbing light at 375 nm provided enough evidence to support the purity of the desired peptide 
(see appendix B). 
 The “Asp-peptide” was first dissolved into DMSO which was then used to test for 
insertion into liposomal cell models. Upon addition of 2 µl of the peptide to a Tris-NO3 buffer 
solution the fluorescence was found to have a λem= 490 nm, (Figure 2.20(a)) which is consistent 
with the λem of compound 2.2 in H2O:DMSO (50:1). Next the peptide solution was added to a 
2.9 mM liposomal solution. Upon addition of 2 µl the λem was found to be 487 nm (Figure 2.18 
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(c)). The max emission is not indicative of the fluorophore being present in a non-polar 
environment, Figure 2.2 (b) above and Figure 2.20 (b). 
 
 
Figure 2.20: Comparative fluorescence spectra of the addition of the “Asp-peptide” to (a) Tris-NO3 buffer, pH 7.4 
(b) dichloromethane (c) a buffered solution of 0.1 µm liposomes (3.0 × 10-3 M) 
 
2.1.8 Conclusion 
 The rising interest in designer peptides, peptido-pharmaceutical agents, and the use of 
selective fluorescent markers has created a need for derivatized Fmoc-protected amino acids. 
Previous studies have shown the utility for fluorescent amino acids that can be used in the 
elucidation of protein structure,(29) fluorescent tagging of cells,(30) and solvatochromic and pH 
sensitivity.(53) Compounds 2.1 and 2.2 were successfully synthesized to give fluorescent amino 
acids with an emission band significantly red-shifted from that of the naturally occurring 
residues tryptophan, tyrosine, and phenylalanine. Amino acids 2.1 and 2.2 are selectively 
sensitive to anions containing a carboxylate group and those that have tetrahedral geometry. 2.1 
54 
 
and 2.2 were both successfully incorporated into a de novo peptide through the use of standard 
solid phase synthesis protocols without limiting residue deprotection or chain lengthening 
reactions later in the sequence. The novel side chains were capable of surviving treatment with 
cocktails containing in excess of 95% trifluoroacetic acid (TFA) when the peptides are cleaved 
from the resin. Future experiments will include further incorporation of amino acids 2.1 and 2.2 
into larger, more robust peptides with the hope that a transmembrane helix will be produced that 
has the ability to discriminately transport anions. 
 
2.2 Experimental Section 
2.2.1 Fluorescence Titrations 
 Fluorescence emission characterization was performed on a PTI QM-4CW system. The 
naphthalimide amino acids were dissolved in spectroscopic grade acetonitrile at a concentration 
in between 1.0 × 10-7 M and 1.0 × 10-6 M. At these concentrations, compounds 2.1 and 2.2 were 
easily soluble in the acetonitrile and did not require any heating or sonication. An absorption 
spectrum was taken to insure that the absorbance was between 0.05 and 0.10. This was 
considered a safe range to achieve a significant signal to noise ratio but stay below the threshold 
that would create interfiltering affects. The titrations were performed on 3.00 mL of sample that 
was measured using a volumetric pipette into a 1 cm path length quartz cuvette. The wavelength 
used for sample excitation was the predetermined λmax from the absorbance spectra previously 
collected. The anions chosen were chloride, bicarbonate, phosphate, and nitrate due to their 
significance in biological systems. The anions were prepared in spectrophotometric grade 
acetonitrile in concentrations of 9.0 × 10-5 M to 1.0 × 10-4 M. The anion solutions were added to 
55 
 
the cuvette in small aliquots using a 10.00 µL glass syringe and allowed to stir for 1 minute 
before a fluorescence spectrum was taken. After a fluorescence titration was completed the area 
of each emission peak was recorded, F, and F0 is for the initial peak integration before the 
introduction of any anion guest. 
 The binding constant Kassoc was calculated for the exponential data by plotting the F / F0 
vs. [anion] and using Equation 2.1. 
𝐹 𝐹0⁄ =  (1 + (𝑘𝑐𝑜𝑚𝑝𝑙𝑒𝑥 𝑘𝑓𝑙𝑢𝑜𝑟𝑜⁄ )𝐾𝑎𝑠𝑠𝑜𝑐[𝑎𝑛𝑖𝑜𝑛]) (1 +  𝐾𝑎𝑠𝑠𝑜𝑐[𝑎𝑛𝑖𝑜𝑛])⁄    eq. 2.1 
Where the values kcomplex and Kassoc were allowed to vary freely, and the constant kfluoro is equal 
to F0/[fluoro]0.
(46,49,50) Where [fluoro]0 is the initial concentration of the fluorophore host before 
and anion guest had been added to the solution. 
 As for the sigmoidal plot given by the complex of 2.1 +bicarbonate the Kassoc was 
calculated from plotting the F / F0 vs. log[anion] and using Equation 2.2. 
𝐹 𝐹0⁄ = 1 + (((𝐹𝑚𝑎𝑥 𝐹0⁄ ) − 1)/(1 + (𝐾𝑎𝑠𝑠𝑜𝑐[𝑎𝑛𝑖𝑜𝑛]𝑡𝑜𝑡𝑎𝑙)
𝑝))    eq. 2.2 
Where Fmax is the integrated intensity at the highest anion concentration, and p is a slope 
parmeter. Both Kassoc and p are allowed to vary freely.
(49,50) 
The collisional quenching constant KSV was calculated from the best fit line by plotting 
the F0 / F vs. [anion] and using Equation 2.3.
(51,50) 
𝐹0 𝐹⁄ =  1 + 𝐾𝑆𝑉[𝑎𝑛𝑖𝑜𝑛]𝑡𝑜𝑡𝑎𝑙        eq. 2.3 
All of the fluorescence titrations were at least repeated twice except for the nitrate 
fluorescence titration with compound 2.1 due to a lack of available pure product.  
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2.2.2 Extinction coefficients 
 The extinction coefficient was recorded for product 2.2 and the results can be found in 
Table 1. The amino acid was dissolved into spectrophotometric grade dichloromethane, 
acetonitrile, and H2O:DMSO (50:1) at a concentration of approximately 6.2 ×10
-5 M. Using a 
volumetric pipette 3.00 mL of sample is transferred to a 1.00 cm quartz cuvette and the 
absorption spectra is obtained using an Agilent Technologies Cary 8454 spectrophotometer. 
Using the Beer’s Law equation: 𝐴 =  𝜀 𝐶 𝑙 the extinction coefficient 𝜀 (M-1 cm-1) can be 
calculated with an experimental absorbance (A) and known concentration (C). 
 
2.2.3 Quantum Yields 
 The quantum yield of compound 2.1 was measured in spectrophotometric grade 1-octanol 
and acetonitrile, the results can be found in Table 2.2. The UV/vis spectra of compound 2.1 (~5.0 
× 10-6 M) was taken to insure that the absorbance was between 0.06 and 0.10. Each sample was 
degassed with nitrogen gas for at least 60 seconds before being capped and inserted in the 
fluorometer. The samples were excited at the previously determined λmax in order to take an 
emission scan. The area under the emission band was recorded (F).  This process was then 
repeated for a standard fluorophore (7-amino-4-methylcoumarin) which has a known quantum 
yield in acetonitrile, Φ = 0.63. To determine the unknown quantum yield of 2.1 in 1-octanol and 
acetonitrile all of the data was plugged into Equation 2.4. 
𝛷𝑢𝑛𝑘 =  
𝐴𝑠𝑡𝑑
𝐴𝑢𝑛𝑘
 ∙  
𝐹𝑢𝑛𝑘
𝐹𝑠𝑡𝑑
 ∙  (
𝜂𝑢𝑛𝑘
𝜂𝑠𝑡𝑑
)
2
 ∙  𝛷𝑠𝑡𝑑       eq. 2.4 
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2.2.4 Liposomes 
 Liposomes were prepared with 1-Palmitoyl-2-oleoylphosphatidylcholine or POPC and 
cholesterol at a ratio of 7:3, lipid to cholesterol. The lipids and cholesterol were first dissolved 
into a 50/50 mixture of dichloromethane and cyclohexane (~ 10 mL) by gently swirling. Once 
the lipids were fully dissolved the solvent was removed in vacuo. The dry lipids were then 
hydrated with a 0.10 M aqueous Tris-HNO3 buffer at pH 7.4. The mixture was magnetically 
stirred for 1 hour. To obtain unilamellar vesicles the liposomes were treated to 3 freeze-thaw 
cycles using liquid nitrogen and room temperature water. The unilamellar vesicles were then 
extruded through a 0.1 µm polycarbonate membrane to achieve liposomes of uniform size. The 
mixture typically takes on an iridescent blue color as confirmation for the formation of 
liposomes. 
 
2.2.5 1H-NMR Titration 
All of the 1H-NMR spectra were collected on a Bruker AVANCE400 spectrometer, 400 
MHz. Compound 2.1 was dissolved into 0.75 mL of DMSO-d6 (7.0 × 10
-4 M) and compound 2.2 
was dissolved into 1.50 mL of DMSO-d6 (3.6 × 10
-4 M). The analyte tetrabutylammonium 
phosphate monobasic is also dissolved into 0.75 mL of DMSO-d6 (5.0 × 10
-2 M for titration of 
compound 2.1 and 5.2 × 10-2 M for titration of compound 2.2). Compound 2.2 was split into two 
tubes each containing 0.75 mL and was also titrated with tetrabutylammonium chloride hydrate 
(6.1 × 10-2 M). An initial spectra was taken of just the plain fluorophore without any anion 
added. The ppm shifts of the N-H proton peaks of the ureido group were recorded. Upon addition 
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of each aliquot of anion the NMR tube was capped and inverted 20 times to ensure complete 
mixing of the solution. This process was repeated until the concentration of the anion in the 
solution was about eight or four times the concentration of the host fluorophore 2.1 and 2.2, 
respectively. The results of the titration can be seen as Figures 2.15, 2.16, and 2.17. 
Association constants were calculated by using the non-linear fitting program 
WinEQNMR.(47) 
 
2.2.6 Computational Modeling Studies 
 Computational modeling calculations were performed with the numerical DFT program 
DMol3,(52,53) where double-numerical plus polarization basis functions with 20.0 Bohr radial 
cutoffs were employed to form the wave function. The Becke-Tsuneda-Hirao gradient-corrected 
exchange-correlation functional (54,55) was employed in the Hamiltonian operator. All calculations 
were performed in the presence of a COSMO (Conductor-like Screening Model) approximation 
to the solvent field with a 36.6 dielectric constant that is appropriate for acetonitrile.(56,57,58) 
 
2.2.7 Synthesis and Characterization 
 (S)-tert-butyl 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(3-(2-butyl-1,3-dioxo-2,3-
dihydro-1H-benzo[de]isoquinolin-6-yl)ureido)propanoate (Compound 2.2, Scheme 2.3) 
Under N2, a mixture of Fmoc-Asp-OtBu (1.05 mmole) and N-methylmorpholine (0.116 mL, 1.05 
mmole) in dry THF (5 mL) was chilled to -20o C and stirred for 5 minutes. Ethyl chloroformate 
(0.102 mL, 1.08 mmole) was slowly added to the solution and allowed to stir for an additional 20 
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minutes. After 20 minutes, a solution of sodium azide (0.111 g, 1.7 mmole) dissolved in 0.75 mL 
of water was added to the reaction and the mixture was warmed to room temperature while 
stirring for 1 hr. Upon completion the solvent was removed by rotary evaporation and the residue 
was dissolved into methylene chloride (20 mL). The organic phase was washed three times each 
with 5% HCl, 5% aq. NaHCO3, and water, and dried with anhydrous sodium sulfate. Rotary 
evaporation removed the methylene chloride and the resulting off-white foamy solid was left on 
high vacuum overnight. The solid acid azide (0.41 g, 0.95 mmole) was dissolved into freshly 
distilled toluene (20 mL) along with 4-amino-N-butylnaphthalimide (0.3 g, 1.1 mmole). The 
reaction mixture is heated to reflux for 14 hrs. The toluene is removed by rotary evaporation and 
the resulting dark orange-brown residue is dissolved into dichloromethane:methanol (9:1). The 
mixture purified via flash chromatography on regular-phase silica gel where the produce can be 
collected as the blue fluorescent band (365 nm light bar). The product is further purified via 
reverse phase HPLC. The product was lyophilized into a dark yellow powder (6%). Mp = 210-
212 oC; 1H-NMR (DMSO-d6, δH ppm, TMS): δ 9.32 (s, 1H), 8.50 (d, 1H), 8.44 (d, 1H), 8.39 (d, 
1H), 8.33 (d, 1H), 7.91 (t, 1H), 7.86 (d, 2H), 7.81 (d, 2H), 7.39 (t, 2H), 7.33 (t, 2H), 7.00 (t,1H), 
6.16 (broad, 1H), 4.80 (dd, 1H), 4.47 (m, 2H), 4.29 (m, 2H), 4.16 (t, 2H), 3.64 (m, 1H), 1.55 (m, 
2H), 1.34 (s, 9H), 1.29 (m, 2H), 0.86 (t, 3H); 13C NMR (DMSO-d6) δ 163.81, 155.03, 142.69, 
141.20, 132.47, 131.48, 128.73, 128.41, 127.52, 126.46. 125.96, 123.37, 122.88, 120.68, 69.20, 
47.10, 30.13, 28.10, 20.28, 14.20; ESI-mass: m/z (positive ion mode) calcd for (M+H+) 
677.2970, found 677.2990. Rf (19:1, DCM:MeOH) = 0.79. 
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(S)-tert-butyl 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(3-(2-butyl-1,3-dioxo-2,3-
dihydro-1H-benzo[de]isoquinolin-6-yl)ureido)butanoate (Compound 2.1, Scheme 2.3) This 
compound was prepared in a similar manner as compound 2a except that Fmoc-Glu-OtBu was 
substituted in as the starting material instead of Fmoc-Asp-OtBu. The resulting lyophilized 
product was a pale green color (5%). Mp = 126 – 127 oC; 1H-NMR (DMSO-d6, δH ppm, TMS): 
δ 9.27 (s, 1H), 8.60 (d, 1H), 8.54 (d, 1H), 8.52 (d, 1H), 8.40 (d, 1H), 7.89 (d, 2H), 7.77 (d, 1H), 
7.72 (d, 2H), 7.41 (t, 2H), 7.33 (t, 2H), 6.99 (t, 1H), 5.91 (broad, 1H), 4.22 - 4.34 (m, 3H), 4.04 
(t, 1H), 3.91 (m, 1H), 3.28 (m, 1H), 3.04 (dm, 2H), 1.68/1.94 (dm, 2H), 1.78 (m, 2H), 1.61 (m, 
2H), 1.39 (s, 9H), 0.93 (t, 3H); 13C NMR (DMSO-d6) δ 172.02, 156.59, 144.26, 141.19, 128.12, 
127.55, 125.74, 120.60, 81.22, 81.00, 66.10, 52.85, 47.11, 28.10, 20.28, 14.21; ESI-mass: m/z 
(positive ion mode) calcd for (M+H+) 691.3126, found 691.3112. Rf (19:1, DCM:MeOH) = 0.82. 
 
2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(3-(2-butyl-1,3-dioxo-2,3-dihydro-1H-
benzo[de]isoquinolin-6-yl)ureido)propanoic acid (Compound 2.5, Scheme 2.3) To convert the 
tert-butyl ester into a carboxylic acid the dark yellow solid 2a is dissolved into a cocktail of 50% 
trifluoroacetic acid, 40% methylene chloride, 5% triethylsilane, and 5% anisole (v/v). The 
mixture is allowed to cleave for 90 minutes, with occasional shaking, before the solvent is 
removed in vacuo. The resulting solid is purified via reverse phase HPLC and lyophilized to give 
a light yellow powder. (63%). Mp = 177 – 178 oC; 1H-NMR (DMSO-d6, δH ppm, TMS): 9.33 (s, 
1H), 8.53 (d, 1H), 8.47 (d, 1H), 8.44 (d, 1H), 8.33 (d, 1H), 7.81 (d, 2H), 7.78 (d, 1H), 7.73 (d, 
1H), 7.65 (dd, 2H), 7.33 (t, 2H), 7.23 (t, 2H), 7.04 (t, 1H), 4.24 (d, 2H), 4.13 – 4.17 (m, 3H), 3.97 
(t, 2H), 3.67 (m, 1H), 1.54 (m, 2H), 1.28 (m, 2H), 0.86 (t, 3H); 13C NMR (DMSO-d6) δ 172.68, 
164.02, 163.44,156.75, 155,11, 144.20, 142.74, 141.20, 132,94, 131.20, 128.98, 128.10, 127.54, 
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126.45, 125.69, 122.89, 122.41, 120.57, 66.29, 54.73, 47.08, 30.19, 20.28, 14.20; ESI-mass: m/z 
(positive ion mode) calcd for (M+H+) 621.2344, found 621.2364. 
 
2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(3-(2-butyl-1,3-dioxo-2,3-dihydro-1H-
benzo[de]isoquinolin-6-yl)ureido)butanoic acid (Compound 2.4, Scheme 2.3) This compound 
was prepared in a similar manner as compound 3a except that 2b was substituted in as the 
starting material instead of 2a. The resulting lyophilized product was a pale green color (80%). 
Mp = 144 – 146 oC; 1H-NMR (DMSO-d6, δH ppm, TMS): δ 12.71 (s, 1H), 9.29 (s, 1H), 8.60 (d, 
1H), 8.54 (d, 1H), 8.52 (d, 1H), 8.40 (d, 1H), 7.89 (d, 2H), 7.75 (t, 1H), 7.73 (d, 2H), 7.42 (t, 
2H), 7.33 (t, 2H), 7.02 (t, 1H), 6.52 (s, 1H), 4.31 (d, 2H), 4.25 (m, 1H), 4.08 (m, 1H), 4.04 (t, 
2H), 3.2 (m, 2H, obscured by water), 1.91 (dm, 2H), 1.61 (m, 2H), 1.35 (m, 2H), 0.93 (t, 3H); 
ESI-mass: m/z (positive ion mode) calcd for (M+H+) 635.2500, found 635.2568. 
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CHAPTER 3: OTHER FLUORESCENT N-FMOC-PROTECTED AMINO ACIDS 
3.1 Results and Discussion 
3.1.1 Diphenylacetylenes 
Before settling on the ureido-naphthalimide compounds that make up the bulk of this 
thesis, several other Fmoc-protected structures were considered. Initially a diphenylacetylene 
moiety was pursued as a possible anion-responsive group. Previous work in the Allen laboratory 
with compounds like Figure 1.6 (see Chapter 1) showed that diphenylacetylenes can be prepared 
in high yield, and are sensitive to their local solvent environment. Target 3.1, adapted from the 
compound in Figure 1.6, was pursued first. The synthetic route to produce compound 3.1 began 
with the formation of the urea group through the coupling of N-Fmoc-protected lysine and 4-
bromophenyl isocyanate (see Scheme 3.1). The bromine found at the para-position from the urea 
could then be used to perform a 
Sonogashira palladium-catalyzed 
coupling reaction to a 
phenylacetylene unit.(18,60) In 
principle, the functional groups 
associated with the 
phenylacetylene could be changed 
to produce a vast library for testing 
how the anion binding ability of 
the amino acid would change (see Scheme 3.1). The coupling between the bromophenyl and 
phenylacetylene was found to be unsuccessful. The reaction was attempted under a battery of 
reaction conditions, changing the reaction solvent, bases, the reaction temperature, and the time. 
Figure 3.1: Fmoc-protected diarylacetylene amino acid 
derivative 3.1. 
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Scheme 3.1: Synthesis of diarylacetylene fluorescent fmoc-protected amino acids. 
 
A Negishi coupling reaction which uses zinc chloride as a precursor catalyst for the 
insertion of palladium at the activated phenyl position was attempted next.(61) The yield was not 
sufficient to justify the extensive purification, which would not have provided enough material 
for solid phase peptide synthesis (SPPS). Suzuki coupling reaction conditions were then 
attempted.(62) Instead of a phenylacetylene unit the reaction called for an aromatic boronic acid, 
which led to the aromatic rings being directly attached. The loss of an acetylene spacer in the 
product was potentially problematic, however. The acetylene extends electronic conjugation in 
the product, which is typically required for generation of long-wavelength absorption/emission. 
The absence of the acetylene unit could be overlooked if the respective boronic acid unit was a 
larger aromatic group that would provide a rigid and extended conjugated system. A pyrene 1-
boronic acid was chosen to couple to the bromophenyl unit (see Scheme 3.2). 
 
 
 
DCM:THF 
1:1 
~45o C / ~18 hrs 
acetonitrile 
DIPEA Pd(PPh3)4, 
~80o C 
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Scheme 3.2: Synthesis of Suzuki coupled diaryl-urea fluorescent fmoc-protected amino 
acids. 
 
After several attempts at the Suzuki coupling the reaction was deemed a failure. Due to 
constraints on time and other resources the production of a non-natural amino acid in this manner 
was abandoned. 
 
3.1.2 Triazoles 
The synthesis of new triazole-based derivatives was found to be easily obtainable through 
the use of azido amino acids and acetylene units. Although the synthesis was a success the 
desired action of anion binding and sensitivity was absent. Compounds 3.2-3.7 found in Scheme 
3.3 were all produced from commercially available materials: either Fmoc-Asn-OH, Fmoc-Gln-
OH, or Fmoc-Lys-OH. The triazole moiety was chosen because it was discovered that triazoles 
are one of the many functional groups that are often found in anion binding molecular 
sensors.(10,63) Triazoles are also easily synthesized via the coupling of an azide with an acetylene 
through a Huisgen 1,3-dipolar cycloaddition.ref The reaction has been termed more colloquially 
DCM:THF 
1:1 
~45o C / ~18 hrs 
dioxane 
Pd(PPh3)4 
, Na2CO3 (aq) 
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as a ‘Click Reaction’ because it could be used to join two pieces of a molecule into a larger 
structure; similar to the clicking together of two toy Lego blocks to form a single larger, 
multicolored block. The formation of a triazole through a click reaction has been shown as an 
effective tool for the introduction of a variety of functional group through interchangeable parts; 
even on superstructures like fullerenes, porphyrin, calices, and liposomes.(64,65,66) The aromatic, 
anion-binding triazole provides a perfect jumping-off point for the production of a library of non-
natural fluorescent amino acid derivatives. 
The synthesis of compounds 3.2-3.5 began with the conversion of the side-chain amide 
group on asparagine and glutamine into a primary amine through a Hofmann rearrangement.(67) 
Compounds 3.6 and 3.7 were derived from Fmoc-Lys-OH, which already has a primary amine as 
the side-chain.  Compounds 3.2-3.7 were then converted into azides through the transfer of a 
diazo unit from imidazole-1-sulfonyl azide hydrochloride via a copper(II) catalyzed reaction.(68) 
The resulting azides were then coupled with two different aryl acetylene units, 1-ethynyl-2,4-
difluorobenzene and 2-ethynyl-6-methoxynaphthalene, using the 1,3-dipolar cycloaddition 
conditions used by Cau et. al.(69) The full synthesis is provided as Scheme 3.1 and the product 
designation is given in Table 3.1. 
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Scheme 3.3: Synthesis of fmoc-protected, fluorescent aryl-triazole containing amino acids 
3.2-3.7. 
 
Table 3.1: Compound number and name of the final products in Scheme 3.1. 
Compound #/ name R = n =  
3.2/ Ala(MNT) a 1 
3.3/ Ala(DFB) b 1 
3.4/ Aha(MNT) a 2 
3.5/ Aha(DFB) b 2 
3.6/ Lys(MNT) a 4 
3.7/ Lys(DFB) b 4 
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Once the non-natural amino acids were synthesized, the spectrophotometric properties 
were evaluated to determine if incorporation into peptides should go forward. Thus, compound 
3.7 was dissolved in dichloromethane and dimethyl sulfoxide (99:1) and a UV/vis spectrum was 
acquired. The compound was found to have a λmax at 276 nm and this was the wavelength used to 
excite the molecule for fluorescence studies. Titrations with both chloride and acetate showed the 
fluorescence behavior to be consistent with collisional quenching, best represented by a Stern-
Volmer plot (Figures 3.2 and 3.3). The Stern-Volmer constants for compound 3.7 with 
tetrabutylammonium chloride and acetate were 7.4 M-1 or 83 M-1, respectively.  
 
 
Figure 3.2: a) Fluorescence quenching of compound 3.7 measured via titration with tetrabutylammonium chloride 
in CH2Cl2:DMSO (99:1) and b) corresponding fluorescence spectra. 
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Figure 3.3: a) Fluorescence quenching of compound 3.7 measured via titration with tetrabutylammonium acetate in 
CH2Cl2:DMSO (99:1) and b) corresponding fluorescence spectra.  
 
Compound 3.2 was also subjected to a fluorescence titration experiment. The electronic 
absorption maximum was determined to be 300 nm; the molecule was excited at this wavelength 
during titration with tetrabutylammonium chloride. Again, the results followed a collisional 
quenching pattern (Figure 3.4).  
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Figure 3.4: Fluorescence spectra of compound 3.2 during titration with tetrabutylammonium chloride in 
CH2Cl2:DMSO (99:1). 
 
Compound 3.2 was also successfully incorporated into the eight residue peptide Ac-Ala-
Ala-Ala-Ala-Ala(MNT)-Ala-Arg-Arg-NH2. This short peptide was synthesized to provide 
evidence that the non-natural amino acid would behave like normal Fmoc-amino acids during 
standard solid phase synthesis protocols. It was shown that the derivatization of the amino acid 
side-chain did not affect its solubility in N,N-dimethylformamide, it could survive interactions 
with piperidine and N,N-diisopropylethylamine, it did not significantly hinder the coupling of 
any residue in the sequence, and it could survive treatment with trifluoroacetic acid, the main 
ingredient used to cleave the finished peptide off of the solid resin. 
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3.1.3 Conclusions 
Compounds 3.2-3.7 must be excited in the UV region (276 or 300 nm) in order to record 
a fluorescence measurement, meaning they are not well-suited to biological applications where 
many intrinsic chromophores might interfere. From the results previously discussed, the 
compounds were also poor receptors for the biologically relevant anions that were the greatest 
concern for this research. Although, 3.1 was not successfully synthesized, the use of a urea 
moiety was reconsidered as the most beneficial anion binding receptor and thus would lead to the 
most desirable results.  A pre-established fluorophore with a red-shifted excitation wavelength 
from that of native amino acids would be needed in order to assure that a finished synthetic 
peptide could eventually be used in a biological system as an analytical tool.(29,32) 
 
3.2 Experimental Section 
3.2.1 Fluorescence Titrations 
 Fluorescence emission characterization was performed on a PTI QM-4CW system. The 
triazole derivatized amino acids were dissolved into spectrophotometric grade dichloromethane 
and dimethylsulfoxide (99:1) at a concentration in between 8.0 × 10-6 and 1.0 × 10-5 M. The 
amino acids would not go directly into dichloromethane and must be first dissolved into DMSO. 
An absorption spectrum was taken of compounds 3.2 and 3.7 were taken to reassure that the 
absorbance was between 0.05 and 0.10 a.u. This was considered a safe range to achieve a 
significant signal to noise ratio with creating interfiltering affects. The titrations were performed 
on 3.00 mL of sample that was measured using a volumetric pipette. The measurements were 
taken in a 1 cm path length quartz cuvette. The wavelength used for sample excitation was 
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determined from the maximum absorbance found through UV/vis experiments. The anions that 
were used were chloride and acetate, obtained through dissolving the tetrabutylammonium salts 
of each in spectroscopic DCM and DMSO (99:1). The anion solutions were dissolved in 
concentrations ranging from 5 × 10-4 to 1 × 10-3 M. The anion solutions were added to the 
cuvette in small aliquots using a 10.00 µL glass syringe and allowed to stir for 1 minute before a 
fluorescence spectrum was taken. After a fluorescence titration was completed the area of each 
emission peak was recorded. The collisional quenching constant KSV was calculated from the 
best fit line by plotting the F0 / F vs. [anion] and using Equation 3.1.
(51,50) 
𝐹0 𝐹⁄ =  1 + 𝐾𝑆𝑉[𝑎𝑛𝑖𝑜𝑛]𝑡𝑜𝑡𝑎𝑙        eq. 3.1 
 
3.2.2 Synthesis and Characterization 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-(6-methoxynaphthalen-2-yl)-1H-
1,2,3-triazol-1-yl)propanoic acid (compound 3.2, Ala(MNT)) Under N2 Fmoc-Asn-OH (1.6 
mmol) is added to a solution of 8 mL N,N-dimethylformamide and 4 mL water along with 
[bis(trifluoroacetoxy)iodo]benzene (2.4 mmole). After stirring for ~15 mins pyridine (6.0 mmol) 
was added and the mixture was allowed to stir vigorously overnight at room tempereature. The 
following morning the solvent was removed through rotary evaporation and the remaining 
viscous residue was dissolved into 10 mL or 6.6 % HCl (v/v). The solution was washed three 
times with 20 mL of diethyl ether and then the aqueous phase was adjusted to a pH of 6 using 2 
M sodium hydroxide. Upon addition of the sodium hydroxide a beige precipitate formed. The 
solid was collected via suction filtration and washed with cold water, cold ethanol, and cold 
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diethyl ether. The solid was collected and dried under reduced pressure overnight. (51-75 % 
yield) 
Under nitrogen the solid Fmoc-Dap-OH (0.82 mmole) was dissolved in a solution 
containing 2.5 mole percent (5.0 mg) of copper (II) sulfate pentahydrate and imidazole-1-
sulfonyl azide hydrochloride (2.6 mmole) in a biphasic mixture of water (4 mL), methanol (7 
mL), and methylene chloride (6 mL). The solution is adjusted to a pH of 9 through the addition 
of three mL of saturated potassium carbonate solution. The reaction mixture is allowed to stir 
vigorously overnight at room temperature. The following morning the reaction mixture is diluted 
with eight additional milliliters of methylene chloride. The aqueous phase is isolated and the 
organic phase is extracted twice with 15 mL of saturated sodium bicarbonate solution. The 
combined aqueous phases were washed twice with 15 mL of diethyl ether and then acidified to a 
pH of 2 with concentrated hydrochloric acid. Upon addition of the hydrochloric acid a white 
precipitate began to form. The aqueous mixture was extracted with three sets of 20 mL of diethyl 
ether. The ether is dried with magnesium sulfate and then removed in vacuo to give a viscous 
yellow oil that was allowed to dry on high vacuum overnight. (31-61 % yield) 
The viscous oil, Fmoc-Ala(N3)-OH (0.26 mmole) was dissolved into a solution of tert-
butanol and water (9:1) along with a  3.0 mole percent of copper (II) sulfate pentahydrate, an 
11.0 mole percent of sodium ascorbate, and 1 equivalent of 2-ethynyl-6-methoxynaphthalene. 
The solution was heated to 55o C and stirred overnight. No product was visible by TLC using a 
50:49:1 methylene chloride, ethyl acetate solution, and formic acid. The mixture was monitored 
over the course of five days before a new spot developed by TLC. The solvent was removed by 
reduced pressure and the crude residue was subjected to flash silica gel column chromatography 
(50:49:1, DCM:EtOAc:formic acid). The spot with an Rf value of 0.32 was collected and the 
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solvent removed by rotary evaporation and left to dry on high vacuum overnight leaving a thin 
yellow film. (7-22 % yield) 1H-NMR (DMSO-d6, δH ppm, TMS): δ 8.28 (s, 1H), 7.94 (d,1H), 
7.87 (m, 5H), 7.64 (m, 3H), 7.37, (m, 2H), 7.35 (s, 1H), 7.26 (m, 2H), 7.19 (d, 1H), 4.87 (dd, 
1H), 4.72 (dd, 1H), 4.59 (m, 1H), 4.24 (m, 1H), 4.22 (m, 2H), 3.98 (s, 3H); 13C NMR (DMSO-
d6) δ 171.15, 157.93, 156.35, 146.86, 144.13, 141.12, 134.35, 129.99, 129.99, 128.08, 127.84, 
127.53, 126.39, 125.67, 125.62, 124.55, 123.88, 122.36, 120.55, 119.60, 106.50, 66.33, 55.70, 
46.97, 25.95; ESI-mass: m/z (positive ion mode) calcd for (M+H+) 535.1981, found 535.1541. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-(2,4-difluorophenyl)-1H-1,2,3-
triazol-1-yl)propanoic acid (compound 3.3, Ala(DFB)) This compound was prepared in a 
similar manner as compound 3.2 except that 1-ethynyl-2,4-difluorobenzene was substituted in as 
a reagent instead of 2-ethynyl-6-methoxynaphthalene. ESI-mass: m/z (positive ion mode) calcd 
for (M+H+) 491.1531, found 491.1401. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(4-(6-methoxynaphthalen-2-yl)-1H-
1,2,3-triazol-1-yl)butanoic acid (compound 3.4, Aha(MNT)) This compound was prepared in a 
similar manner as compound 3.2 except that instead of starting with Fmoc-Asn-OH the amino 
acid Fmoc-Gln-OH was used to extend the side chain by one methylene unit. 
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(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(4-(2,4-difluorophenyl)-1H-1,2,3-
triazol-1-yl)butanoic acid (compound 3.5, Aha(DFB)) This compound was prepared in a 
similar manner as compound 3.4 except that 1-ethynyl-2,4-difluorobenzene was substituted in as 
a reagent instead of 2-ethynyl-6-methoxynaphthalene. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-(4-(6-methoxynaphthalen-2-yl)-1H-
1,2,3-triazol-1-yl)hexanoic acid (compound 3.6, Lys(MNT)) This compound was prepared in a 
similar manner as compound 3.2 except that the initial conversion of a side-chain amide group 
into a primary amine was unnecessary because the starting material was Fmoc-Lys-OH which 
already contains an primary amino group on its side chain. ESI-mass: m/z (positive ion mode) 
calcd for (M+H+) 577.2451, found 577.2029. 
 
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-(4-(2,4-difluorophenyl)-1H-1,2,3-
triazol-1-yl)hexanoic acid (compound 3.7, Lys(DFB)) This compound was prepared in a similar 
manner as compound 3.6 except that 1-ethynyl-2,4-difluorobenzene was substituted in as reagent 
instead of 2-ethynyl-6-methoxynaphthalene. ESI-mass: m/z (positive ion mode) calcd for 
(M+H+) 533.2000, found 533.1526. 
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APPENDIX A: FLUORESCENE TITRATION SPECTRA AND CURVE FITS 
2.1 + H2PO4- 
 
 
 
83 
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2.1 + HCO3- 
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2.1 + HCO3- 
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2.1 + HCO3- 
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2.1 + HCO3- 
 
(A Fluorescence titration performed on a less concentrated host solution than used in the 
titrations that gave a sigmoidal shaped curve (Reference Figures 2.5 and 2.6)) 
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2.1 + Cl- 
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2.1 + NO3- 
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2.2 + H2PO4- 
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2.2 + H2PO4- 
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2.2 + H2PO4- 
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2.2 + Cl- 
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3.7 + Cl- 
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3.7 + CH3COO- 
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3.2 + Cl- 
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APPENDIX B: 1H-NMR, MASS SPECTROSCOPY, AND HPLC 
 
 
 
 
(a) YKKEIAHALFSA-NH2 CONTROL PEPTIDE 
(b) YKK-E*-IAHALFSA-NH2 FLUORESCENT PEPTIDE WITH 2.1 DERIVATIVE 
 
Histidine 
Phenylalanine 
Tyrosine 
5H signals for 
naphthalimide fluorophore 
(a) 
(b) 
100 
 
 
YKK-E*-IAHALFSA-NH2 fluorescent peptide with 2.1 derivative (HRMS ESI calcd for 
(M+H)+ 1641.8900, found 1641.6640. Calcd for (M+2H)2+ 821.4486, found 821.3583. Calcd 
for (M+Na+H)2+ 832.4396, found 832.3498. Calcd for (M+2Na)2+ 843.4306, found 843.3474. 
101 
 
 
 
YKKEIAHAL-D*-SA-NH2 fluorescent peptide with 2.2 derivative (HRMS ESI calcd for 
(M+H)+ 1609.8485, found 1609.5603. Calcd for (M+2H)2+ 805.4279, found 805.2852. Calcd 
for (M+Na+H)2+ 816.4189, found 816.2787. Calcd for (M+2Na)2+ 827.4099, found 827.2510. 
102 
 
 
HPLC trace of YKKEIAHAL-D*-SA-NH2 with the peak at Rt = 1584 seconds. The method 
used was as follows: Flow rate 1.00 mL/min, Buffer A: acetonitrile/0.1% TFA, Buffer B: 
Water/0.1% TFA. Start, Isocratic Flow (A:B, 10:90) 2 min, Load/Inject Sample (0.250 mL), 
Zero Baseline, Linear Gradient (A:B, 10:90 → 50:50) 30 min, Isocratic Flow (A:B, 50:50) 5 
min, Linear Gradient (A:B, 50:50 → 100:0) 5 min, Isocratic Flow (A:B, 100:0) 3 min, 
Linear Gradient (A:B, 100:0 → 10:90) 5 min, Isocratic Flow (A:B, 10:90) 2 min, End of 
Protocol. YKKEIAHAL-D*-SA-NH2 eluted at A:B = 42:58 detected by 375 nm light. 
YKKEIAHAL-D*-SA-NH2 
